Session Chair Profile

M.D., FACOG, Gynecologist, UCSF, Sutter Health

Dr. Kagan is a board certified obstetrician-gynecologist and has been practicing gynecology and teaching medical students and residents for over 35 year. She specializes in gynecology, specifically menopause related health conditions, quality of life, bone health, female sexuality, and female cancer survivorship. She was co-medical director and principal investigator for multiple clinical trials at the Foundation for Osteoporosis Research and Education (FORE) in Oakland, CA, and more recently has been doing menopause related clinical research with the Sutter Health Research Institute. She is a North American Menopause Society (NAMS) certified Menopause Practitioner (NCMP) and is certified by the International Society of Clinical Densitometry (CCD). She serves on many committees developing standards for women’s health in midlife and beyond. She is actively involved in several professional organizations including NAMS, and is a past Board Trustee, Scientific Program Chair and continues to serve on the NAMS Scientific Program Committee. She is an active committee member of the International Menopause Society (IMS) and International Society for the Study of Women’s Sexual Health (ISSWSH). Dr. Kagan is well known as a communicator and teacher and is often approached by media, public forums, and colleagues to lecture at national and international scientific meetings for her expertise in menopause and osteoporosis. She is currently on the Medical and Scientific Advisory Board of American Bone Health (ABH), an Advisor for Lisa Health and on the Provider Executive Group for Ms. Medicine.Dr. Kagan is a graduate of New York University and the Albany Medical College of Union University. She completed her internship-residency at the University of California San Francisco and has been on the clinical faculty since then.

 Session Abstract – PMWC 2022 Silicon Valley

Track Co-Chairs:
Aleksandar Rajkovic, UCSF

Researchers have long been recognizing the uniqueness of women’s health and its substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared to men. This Track will focus on the following topics related to Women’s Health:

  • Intro to Women's Health
    - Aleksandar Rajkovic, UCSF
  • Reproductive Health
    - Hakan Cakmak, UCSF
    - Laura Jelliffe-Pawlowski, UCSF
  • Pregnancy (PANEL)
    Session Chair: Yoel Sadovsky, University of Pittsburgh
    - Virginia D. Winn, Stanford
    - Ananth Karumanchi, Cedars-Sinai Medical Center
    - Mira Moufarrej, Stanford University
    - Liang Liang, 9 MONTHS
  • Carrier Screening: Perspective on the new ACMG Practice Resource
    - James D Goldberg, Women's Health Medical Affairs
  • Biological Sex Differences in Disease + Inclusion of Women in Clinical Research/Innovation
    - Rhonda Voskuhl, UCLA
  • Cardiovascular Health
    - Nisha Parikh, UCSF
    - Jennifer Ann Tremmel, Stanford
  • Bone Health/Osteoporosis & Menopause (PANEL)
    Session Chair: Risa Kagan, UCSF, Sutter Health
    - Danit Ariel, Stanford
    - Massimiliano (Max) de Zambotti, SRI International
  • Showcase
    - Carrie Haverty, Mirvie
    - Brian D. Brohman, NX Prenatal
    - Ripudaman Singh, ARCEDI Biotech
    - Claire Tomkins, Future Family
    - Donna Russell, Precia Group
    - Adam de la Zerda, Visby Medical, Inc.